Aberrant methylation of human L- and M-fructose 1,6-bisphosphatase genes in cancer
Aberrant methylation of human L- and M-fructose 1,6-bisphosphatase genes in cancer
复制标题
DOI:
10.1016/j.bbrc.2008.10.045
复制
发表时间:
2008-12-12
影响因子:
3.1
通讯作者:
Eschrich, Klaus
中科院分区:
文献类型:
--
作者:
Bigl, Marina;Jandrig, Burkhard;Eschrich, Klaus
A possible epigenetic regulation of the two isoenzymes of fructose 1,6-bisphosphatase (FBPase) was studied in liver, muscle, mamma, breast cancer and in different cancer cell lines. Results obtained after bisulfite sequencing revealed a different CpG methylation of both promoters in liver, muscle and breast tissue which is putatively involved in the cell-type specific gene expression of the two enzymes. In tumor cell lines, demethylation with 5-aza-deoxycytidine activated the expression of both isoenzymes. Additional inhibition of histone deacetylase with trichostatin A further increased FBPase mRNA concentrations. Since cancers typically have an abnormal energy metabolism and exhibit a low gluconeogenic phenotype, it was studied whether promoter methylation contributes to the decreased expression of FBPase in breast cancer. When non-malignant and malignant tissue samples from the same patient were compared a correlation between an increase of FBPase promoter methylation and a decrease of FBPase mRNA levels was observed. (C) 2008 Elsevier Inc. All rights reserved.